eISSN: 2450-5722
ISSN: 2450-5927
Journal of Health Inequalities
Current issue Archive Online first About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
1/2016
vol. 2
 
Share:
Share:
abstract:
Original paper

New challenges for cervical cancer

Cezary Wojtyła
1
,
Aneta Słabuszewska-Jóźwiak
1
,
Kinga Janik-Koncewicz
2
,
Witold A. Zatoński
2

  1. Centre of Postgraduate Medical Education, First Department of Obstetrics and Gynaecology, Warsaw, Poland
  2. Department of Cancer Control and Epidemiology, Maria Curie-Sklodowska Memorial Cancer Centre, Warsaw, Poland
J Health Inequal 2016; 2 (1): 77–88
Online publish date: 2016/07/29
View full text Get citation
 
PlumX metrics:
One of the most common types of cancer found in women throughout the world is cancer of the cervix. Nationwide screening programmes, as commonly used in the developed world, have demonstrated significantly reduced rates of cervical cancer, thus in such cases leading to decreased mortality rates. In developing countries, indicators of cervical cancer are increasing. In Poland, as in other countries, we can observe a significant disproportion of its occurrence among different populations of women. During the first half of the 1990s, cervical cancer was the second most prevalent cancer in Poland. Since then its morbidity and mortality rates have gradually decreased. This trend has continued on from the second half of the 1980s, when the standardised morbidity rate decreased to 17.2/100,000 women. In 2010 this further decreased to 10.3/100,000 women. In the early seventies, the standardised mortality rate for cervical cancer in Poland was 9.2/100,000 women. At the moment, the cervical cancer mortality rate in Poland is 5.2/100,000 women. Nevertheless, we still observe higher rates of morbidity and mortality from cervical cancer compared to other developed countries. Following European Commission recommendations, Poland launched a nationwide programme for cytological screening in 2007. In 2009, 26.77% of women took part in the cervical screening programme. Data from subsequent years have not been published, but even if an upward trend is maintained within the first years of the programme, it seems that only around 1/3 of Polish women are covered. The low screening level is a major drawback in the attempt to reduce cervical cancer rates in Poland. We also do not have precise data on how many actual Pap tests are performed or on those women who have never had such tests done. It therefore seems necessary that such data be obtained to enable a high risk group of death from cervical cancer to be defined and appropriate countermeasures to be undertaken.
keywords:

cervical cancer, cervical cytology, human papillomavirus (HPV), human papillomavirus vaccination, cancer prevention


Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.